Picture of Telix Pharmaceuticals logo

TLX Telix Pharmaceuticals Balance Sheet

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual balance sheet for Telix Pharmaceuticals, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments44.677.922116123
Net Total Accounts Receivable
Net Total Receivables1314.220.845.971.9
Total Inventory
Prepaid Expenses
Total Current Assets58.793.647.5173225
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1.94.826.3318.830.5
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets103158110255398
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities10.6203885.6157
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities32.578.8108175249
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity70.1792.1680149
Total Liabilities & Shareholders' Equity103158110255398
Total Common Shares Outstanding